Company Description
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally.
The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand.
Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com.
Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
| Country | United States |
| Founded | 2009 |
| IPO Date | Apr 5, 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Ms. Janet Hall |
Contact Details
Address: 2925 Richmond Avenue, Suite 1200 Houston, Texas 77098 United States | |
| Phone | (800) 873-5141 |
| Website | guardionhealth.com |
Stock Details
| Ticker Symbol | GHSI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001642375 |
| CUSIP Number | 40145Q203 |
| ISIN Number | US40145Q5009 |
| Employer ID | 47-4428421 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Robert Neal Weingarten | Independent Chairman and Secretary |
| Craig J. Sheehan | Chief Commercial Officer |
| Janet Hall | President and Chief Executive Officer |
| Katie Cox | Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 9, 2024 | 8-K | Current Report |
| Apr 8, 2024 | DEFM14A | Filing |
| Apr 2, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 1, 2024 | 8-K | Current Report |
| Mar 29, 2024 | 10-K | Annual Report |
| Mar 21, 2024 | PREM14A | Filing |
| Mar 15, 2024 | PRE 14A | Other preliminary proxy statements |
| Feb 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 31, 2024 | 425 | Filing |